• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dis. Stillbirth during infection with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Giuseppe

Emeritus
[Source: Journal of Infectious Diseases, full page: (LINK). Abstract, edited.]


Stillbirth during infection with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Daniel C. Payne 1, Ibrahim Iblan 2, Sultan Alqasrawi 3, Mohannad Al Nsour 4, Brian Rha 1,5, Rania A. Tohme 6, Glen R. Abedi 1, Noha H. Farag 7, Aktham Haddadin 8, Tarek Al Sanhouri 8, Najwa Jarour 3, David L. Swerdlow 1, Denise J. Jamieson 9, Mark A. Pallansch 1, Lia M. Haynes 1, Susan I. Gerber 1, Mohammad Mousa Al Abdallat 3, the Jordan MERS-CoV Investigation Team

Author Affiliations: <SUP>1</SUP>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA <SUP>2</SUP>Jordan Field Epidemiology Training Program, Amman, Jordan <SUP>3</SUP>Communicable Diseases Directorate, Jordan Ministry of Health, Amman, Jordan <SUP>4</SUP>Eastern Mediterranean Public Health Network (EMPHNET), Amman, Jordan <SUP>5</SUP>Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA <SUP>6</SUP>Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA <SUP>7</SUP>Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA <SUP>8</SUP>Directorate of Laboratories, Jordan Ministry of Health, Amman, Jordan <SUP>9</SUP>Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Correspondence: Daniel C. Payne, PhD, MSPH (Tele) 404-639-2784 DVP6@CDC.GOV, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Mailstop A-34, Atlanta, Georgia, 30333 U.S.A.

<CITE><ABBR>J Infect Dis.</ABBR> (2014) doi: 10.1093/infdis/jiu068 </CITE>First published online: January 28, 2014


Abstract

We conducted an epidemiologic investigation among survivors of a Middle East Respiratory Syndrome coronavirus (MERS-CoV) outbreak in Jordan. A second trimester stillbirth occurred during the course of an acute respiratory illness which was attributed to MERS-CoV, based on exposure history and positive MERS-CoV serology. This is the first occurrence of stillbirth during an infection with MERS-CoV and may have bearing upon the surveillance and management of pregnant women in settings of unexplained respiratory illness potentially due to MERS-CoV. Future prospective investigations of MERS-CoV should ascertain pregnancy status and obtain further pregnancy?related data, including biological specimens for confirmatory testing.


Received December 4, 2013. Revision received January 22, 2014. Accepted January 23, 2014.

Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.


-
------
 
Back
Top Bottom